Reduced glucose uptake with markedly increased gastrin releasing peptide, osteopontine & asbestos found in dark black areas of PET Scan of chest wall in patient with mesothelioma

Acupuncture and Electro-Therapeutics Research

Volumn 31, Issue 3-4, 2006, Pages 247-257

  Omura, Yoshiaki ^a,b,c,d,h   Shimotsuura, Yasuhiro ^e,f   Duvvi, Harsha ^b   Ohata, Naoki ^g   Ohki, Motomu ^e  

^a Heart Disease Research Foundation   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

^c Int'l College of Acupuncture and Electro Therapeutics   (United States)

^d BOGOMOLETS NATIONAL MEDICAL UNIVERSITY   (Ukraine)

^e ORT Life Science Research Institute   (Japan)

^f Japan Bi Digital O Ring Test Medical Society   (Japan)

^g Dental Division of Japan Bi Digital O Ring Test Medical Society   (Japan)

^h NONE   (United States)

Author keywords

Asbestos; Blood pro gastrin releasing peptide; Cancer; Gastrin releasing peptide; Glucose uptake; Malignant tumor; Mesothelioma; Osteopontine; PET scan with radioactive flurodeoxyglucose; Telomere

Indexed keywords

ACETYLCHOLINE; ASBESTOS; FLUORODEOXYGLUCOSE F 18; GASTRIN RELEASING PEPTIDE; GLUCOSE; HYALURONIC ACID; OSTEOPONTIN; PROGASTRIN RELEASING PEPTIDE; THROMBOXANE B2; VERY LATE ACTIVATION ANTIGEN 5;

ADULT; ARTICLE; CASE REPORT; DIAGNOSTIC IMAGING; DISEASE MARKER; GLUCOSE TRANSPORT; HUMAN; IMAGE ANALYSIS; MALE; MESOTHELIOMA; POSITRON EMISSION TOMOGRAPHY; THORAX SCINTISCANNING; THORAX WALL; TISSUE DISTRIBUTION;

EID: 34250807230     PISSN: 03601293     EISSN: None     Source Type: Journal    
DOI: 10.3727/036012906815844256     Document Type: Article

References (12)

1. Carbone M, Pass H.I., Rizzo p., Marinetti M., Di Muzio M., Mew D.J., Levine A.S., Procopio A. Simian Virus 40-like DNA Sequences in Human Pleural Mesothelioma. Oncogene. 9(6): 1781-1790, 1994.
2. Lee W.C., Testa J.R. Somatic Genetic Alterations in Human Malignant Mesothelioma. International Journal of Oncology. 14(1): 181-188, 1999.
3. Foddis R., De Rienzo A., Broccoli D., Bocchetta M., Stekala E., Rizzo P., Tosolini A., Grobelny J.V., Jhanwar S.C., Pass H.I., Testa J.R., Carbone M. SV40 Infection Induces Telomerase Activity in Human Mesothelial Cells. Oncogene. 21(9): 1434-1442, 2002.
4. Omura, Y. Asbestos As a Possible Major Cause of Malignant Lung Tumors (Including Small Cell Carcinoma, Adenocarcinoma, & Mesothelioma), Brain Tumors (i.e. Astrocytoma & Glioblastoma Multiforme(, Many Other Malignant Tumors, Intractable Pain Including Fibromyalgia, & Some Cardio-Vascular Pathology: Safe & Effective Methods of Reducing Asbestos From Normal & Pathological Areas. Acupuncture & Electro-Therapeutics Rsearch. The International Journal. 31:61-125, 2006.
5. Omura, Y. Beneficial Effects & Side Effects of DHEA: True Anti-Aging & Age-Promoting Effects, as Well as Anti-Cancer & Cancer-Promoting Effects of DHEA Evaluated From the Effects on the Normal & Cancer Cell Telomeres & Other Parameters. Acupuncture & Electro-Therapeutics Research. The International Journal. 30: 219-261, 2005.
6. Ordonez N.G. The Immunohistochemical Diagnosis of Mesothelioma: a comparative Study of Epithelioid Mesothelioma and Lung Adenocarcinoma. American Journal of Surgical Pathology. 8:1031-1051, 2003.
7. Pass H.I., Lott D., Lonardo F., Harbut M., Liu Z., Tang N., Carbone M., Webb C., Wali A. Asbestos Exposure, Pleural Mesothelioma, and Serum Osteopontin Levels. The New England Journal of Medicine. 353:1564-1573, 2005,
8. Wang ZJ, Reddy GP, Gotway MB, Higgins CB, Jablons DM, Ramaswamy M, Hawkins RA, Webb WR. Malignant Pleural Mesothelioma: Evaluation with CT, MR Imaging, and PET. Radiographics. 24:105-119, 2004.
9. Sterman DH, Kaiser LR, Albelda SM. Advances in the Treatment of Malignant Pleural Mesothelioma. CHEST. 116:504-520, 1999.
10. Duysinx B, Nguyen D, Louis R, Cataldo D, Belhocine T, Bartsch P, Bury T. Evaluation of Pleural Disease With 18-Fluorodeoxyglucose Positron Emission Tomography Imaging. CHEST. 125: 489-493, 2004.
11. Flores R, Akhurst T, Gonen M, Zakowski M, Dycoco J, Larson S, Rusch VW. Positron Emission Tomography Predicts Survival in Malignant Pleural Mesotheliioma. The Journal of Thoracic and Cardiovascular Surgery. 132(4): 763-768, 2006.
12. 18F] Fluorodeoxyglucose. Journal of Clinical Oncology, 24(28): 4587-4593, 2006.